What even is this company anymore?
The language has changed from we are a P3 company to we are doing the first part of 2 P3s to we are desperately hoping the FDA will let us get close to being a P3.
LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.015(3.75%) |
Mkt cap ! $153.0M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.5¢ | $274.6K | 702.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 62183 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |